Clinical trial
Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or…
NCT00006942 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00006942 |
|---|---|
| Title | Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer |
| Official title | A Phase II Trial of Bryostatin in Combination With Cisplatin in Patients With Recurrent or Persistent Epithelial Ovarian Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer |
| Intervention type | Drug, Other |
| Interventions | bryostatin 1, cisplatin, laboratory biomarker analysis |
| Enrollment | 32 |
| Start date | Oct 1, 2000 |
| Primary completion | Mar 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: